AcelRx Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
TLPH
CUSIP
00444T209
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 00444T209 since 12/18/2024, largest first.

Filer % of Class Filed
CorMedix Inc. 13D 20.0% 9/12/2025
Event 9/7/2025
Nantahala Capital Management, LLC 13D/A
11.7% 4/3/2025
Event 3/31/2025
Rosalind Advisors, Inc. 13G/A
9.9% 11/13/2026
Event 9/30/2026
Orin Hirschman 13G/A
9.8% 1/30/2026
Event 12/31/2025
Rock Springs Capital Management LP 13G
7.9% 9/12/2025
Event 9/10/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Lytton Laurence W 13G/A
2.5% 5/15/2026
Event 3/31/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 51 22.2 M $25.8M
2026 Q2 51 23.9 M $24.6M
2026 Q1 46 21.9 M $16.3M
2025 Q4 39 20.9 M $23.8M
2025 Q3 37 17.8 M $15.9M
2025 Q2 33 5.28 M $2.43M
2025 Q1 35 5.52 M $2.74M
2024 Q4 37 4.08 M $2.14M
2024 Q3 30 4.18 M $3.58M
2024 Q2 32 4.35 M $3.87M
2024 Q1 33 4.42 M $4.56M
2023 Q4 35 4.02 M $5.92M
2023 Q3 32 3.25 M $1.88M
2023 Q2 28 1.06 M $1.17M
2023 Q1 35 1.10 M $721k
2022 Q4 37 1.45 M $3.28M